Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

New York, New York 10032


Investigators are hoping to learn if glucosamine with chondroitin can help relieve joint pain/stiffness associated with aromatase inhibitors


Inclusion Criteria: - Age >21 years - Postmenopausal status defined as cessation of menses for >1 year or FSH >20 mIU/mL - History of stage I, II or IIIA hormone receptor-positive breast cancer, without metastatic disease - Currently taking a third-generation aromatase inhibitor for at least 3 months - Clinical symptoms of knee and/or hand joint pain and/or stiffness for at least 3 months prior to study entry - Ongoing musculoskeletal pain/stiffness in hand and/or knee joints (50 or higher on the 100 point global assessment VAS) that started or increased since initiating aromatase inhibitor therapy, and has been present for at least 3 months. - patients must agree to refrain from use of glucosamine and chondroitin from sources outside of this study - If taking bisphosphonates, on a stable dose for at least 3 months and tolerating the dose. Patients must agree to refrain from initiating bisphosphonate use during the course of the study. - ECOG performance status 0-2. - Hemoglobin A1c <8. - Signed informed consent Exclusion Criteria: - se of glucosamine or chondroitin within the past six months - Concurrent medical/arthritic disease that could confound or interfere with evaluation of pain or efficacy including: - Inflammatory arthritis (e.g., rheumatoid arthritis, systemic lupus, spondyloarthropathy, psoriatic arthritis, polymyalgia rheumatica) - gout - episodes of acute monarticular arthritis clinically consistent with pseudogout - Paget's disease affecting the study joint - a history of septic arthritis or avascular necrosis or intra-articular fracture of the study joint - Wilson's disease - hemochromatosis - alkaptonuria - primary osteochondromatosis - History of significant collateral ligament, anterior cruciate ligament or meniscal injury of the index joint requiring surgery or non-weight bearing (requiring use of crutches or cane) for more than 3 weeks (minor ligamentous injury prior to 6 months is not an exclusion). - History of bone fracture or surgery of the afflicted knees and/or hands within 6 months prior to study entry. - AST, ALT > 2x normal. - Serum Creatinine of > 1.8 mg/dl. - Uncontrolled hypertension (Systolic Blood Pressure of > 150 mm Hg or Diastolic Blood Pressure of >95 mm Hg). - Uncontrolled diabetes mellitus, defined as Hemoglobin A1c level of > 8%.



Primary Contact:

Principal Investigator
Dawn Hershman, MD
Columbia University

Backup Contact:


Location Contact:

New York, New York 10032
United States

There is no listed contact information for this specific location.

Site Status: N/A

Data Source: ClinicalTrials.gov

Date Processed: October 09, 2019

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.

Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.